SCHEMBL25848565

SCHEMBL25848565

CC1(C)C(O)CCC1Oc1ccc2cc(-c3ccccc3)c(=O)oc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.58
RAB9A P51151 7/20 0.58
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
KDM4E B2RXH2 3/20 0.56
GLA P06280 2/20 0.56
KLK7 P49862 1/20 0.52
ALDH1A1 P00352 2/20 0.51
GAA P10253 1/20 0.51
HPGD P15428 1/20 0.51
RECQL P46063 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HSD17B10 Q99714 1/20 0.51
MIF P14174 2/20 0.49
ACHE P22303 2/20 0.45
RXFP1 Q9HBX9 2/20 0.45
MAOB P27338 1/20 0.45
SIRT3 Q9NTG7 1/20 0.45
ERAP1 Q9NZ08 1/20 0.45
ABCB1 P08183 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625524 0.88 NPC1 (0.54) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848274 0.84 NPC1 (0.53) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848276 0.84 NPC1 (0.55) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL22625161 0.78 NPC1 (0.51) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL22625067 0.78 NPC1 (0.48) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL25848569 0.78 NPC1 (0.59) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL22625474 0.78 NPC1 (0.48) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL22625461 0.76 NPC1 (0.46) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL22625460 0.75 NPC1 (0.45) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL4358139 0.74 NPC1 (1.00) NPC1RAB9AMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 NPC1 1051/4885RAB9A 1916/4885MEN1 3033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.